ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

ALNFL NFL Biosciences SA

1.66
0.004 (0.24%)
10 Mar 2025 - Closed
Delayed by 15 minutes

NFL Biosciences Financial Summary

The current ALNFL market cap is 15.96M. The company's latest EPS is EUR -0.3895 and P/E is -4.26.

Year End 31 December 2023 20192020202120222023
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Total Revenue 0000200k
Operating Income -347k-318k-902k-3.08M-4.23M
Net Income -267k-261k-978k-2.44M-3.75M
Year End 31 December 2023 20192020202120222023
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Total Assets 467k577k3.69M2.4M3.97M
Total Liabilities 56k427k398k1.55M3.62M
Total Equity 411k150k3.29M844k350k

Cash Flow

Year End 31 December 2023 20192020202120222023
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Operating N/A N/A N/A N/A N/A
Investing N/A N/A N/A N/A N/A
Financing N/A N/A N/A N/A N/A
Market Cap 15.96M
Price to Earnings Ratio -4.26
Price to Sales Ratio 79.81
Price to Cash Ratio 6.83
Price to Book Ratio 45.6
Dividend Yield -

Share Statistics

Shares Outstanding 9.61M
Average Volume (1 week) 22.61k
Average Volume (1 Month) 16.23k
52 Week Change -30.11%
52 Week High 3.28
52 Week Low 1.61
Spread (Intraday) 0.04 (2.41%)

Company Info

Company Name NFL Biosciences SA
Address 199 rue helene boucher
castelnau-le-lez 34170
Website https://www.nflbiosciences.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock